A novel genetic modifier of p53, mop1, results in embryonic lethality

Mammalian Genome

Volumn 15, Issue 6, 2004, Pages 415-423

  Evans, Susan C ^a   Liang, Min ^a   Amos, Christopher ^b   Gu, Xiangjun ^b   Lozano, Guillermina ^b  

^a OHIO UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ALLELE; ANIMAL EXPERIMENT; ARTICLE; CENTROMERE; CHROMOSOME 11; CHROMOSOME NOR; DNA POLYMORPHISM; EMBRYO; FAMILIAL CANCER; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETICS; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; MALE; MOUSE; NONHUMAN; PROGENY;

ANIMALS; CHROMOSOME MAPPING; GENES, LETHAL; GENES, RECESSIVE; GENETIC MARKERS; LI-FRAUMENI SYNDROME; LOD SCORE; MICE; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 2542426378     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00335-004-2327-y     Document Type: Article

References (33)

1. Almog N, Rotter V (1997) Involvement of p53 in cell differentiation and development. Biochim Biophys Acta 1333, F1-27
2. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR (1995) High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 5, 931-936
3. Barlow C, Liyanage M, Moens PB, Deng CX, Ried T, Wynshaw-Boris A (1997) Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nat Genet 17, 462-466
4. Bascom-Slack CA, Ross LO, Dawson DS (1997) Chiasmata, crossovers, and meiotic chromosome segregation. Advances in Genetics 35, 253
5. Choi J, Donehower LA (1999) p53 in embryonic development: maintaining a fine balance. Cell Mol Life Sci 55, 38-47
6. Cottingham RW, Idury Jr., RM, Schaffer AA (1993) Faster sequential genetic linkage computations. Am J Hum Genet 53, 252-263
7. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel Jr., JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221
8. Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery CA, Park Jr., SH, Thompson T, Ford RJ, Bradley A (1995) Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog 14, 16-22
9. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M (1996) p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol Cell Biol 16, 5178-185
10. Evans SC, Lozano G (1997) The Li-Fraumeni syndrome: an inherited susceptibility to cancer. Mol Med Today 3, 390-395
11. Evans SC, Mims B, McMasters KM, Foster CJ, deAndrade M, Amos CI, Strong LC, Lozano G (1998) Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family. Hum Genet 102, 681-686
12. Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M, Fraumeni J Jr., Li FP, Friend SH (1995) Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 56, 608-615
13. Hakem R, de la Pompa JL, Elia A, Potter J, Mak TW (1997) Partial rescue of Brcal (5-6) early embryonic lethality by p53 or p21 null mutation. Nat Genet 16, 298-302
14. Harvey M, McArthur MJ, Montgomery CA Jr., Bradley A, Donehower, LA (1993) Genetic background alters the spectrum of tumors that develop in p53-deficient mice. Faseb J 7, 938-943
15. Heston WE (1963) Genetics of neoplasia. In: Methodology in mammalian genetics WJ Burdette ed Holden-Day San Francisco pp. 247-268
16. Hodge SE, Elston RC (1994) Lods, wrods, and mods: the interpretation of lod scores calculated under different models. Genet Epidemiol 11, 329-342
17. Hwang S-J, Lozano G, Amos CI, Strong LC (2003) Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet 72, 975
18. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4, 1-7
19. Jones SN, Roe AE, Donehower LA, Bradley A (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206-208
20. Kleihues P, Schauble B, zur Hausen A, Esteve J, Ohgaki H (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 150, 1-13
21. Lim DS, Hasty P (1996) A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol Cell Biol 16, 7133-7143
22. Ludwig T, Chapman DL, Papaioannou VE, Efstratiadis A (1997) Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev 11, 1226-1241
23. MacLean CJ, Bishop DT, Sherman SL, Diehl SR (1993) Distribution of lod scores under uncertain mode of inheritance. Am J Hum Genet 52, 354-361
24. de MontesOca Luna R, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206
25. Murphy ED (1966) Characteristic tumors. In: Biology of the laboratory mouse Green EL ed 2 New York, McGraw-Hill, pp. 521-562
26. Nicol CJ, Harrison ML, Laposa RR, Gimelshtein IL, Wells PG (1995) A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat Genet 10, 181-187
27. rd ed. Baltimore, Johns Hopkins University Press,
28. Pani L, Horal M, Loeken MR (2002) Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev 16, 676-80
29. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T (1995) A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 10, 175-80
30. Strong LC, Stine M, Norsted TL (1987) Cancer in survivors of childhood soft tissue sarcoma and their relatives. J Natl Cancer Inst 79, 1213-20
31. Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DG, Birch JM (1997) Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57, 3245-52
32. Vogel KS, Parada LF (1998) Sympathetic neuron survival and proliferation are prolonged by loss of p53 and neurofibromin. Mol Cell Neurosci 11, 19-28
33. Weir BS (1996) Genetic Data Analysis II. Sunderland, Sinauer Associates, Inc.